224 related articles for article (PubMed ID: 38390434)
21. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
Chatterjee S; Premachandran S; Shukla J; Poduval TB
J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
[TBL] [Abstract][Full Text] [Related]
22. [The protective effect of different doses of dexamethasone on acute kidney injury induced by sepsis in mice].
Yang J; Wu DW; Tang LN; Lu HN; Zhang F; Guo HP; Hu Z; Huang SY
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):424-8. PubMed ID: 23834942
[TBL] [Abstract][Full Text] [Related]
23. Dexmedetomidine Protects Against Septic Liver Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT1 Signaling Pathway.
Yu Q; Zou L; Yuan X; Fang F; Xu F
Front Pharmacol; 2021; 12():658677. PubMed ID: 33981237
[No Abstract] [Full Text] [Related]
24. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
Visser K; Smith C; Louw A
Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
[TBL] [Abstract][Full Text] [Related]
25. Early use of dexamethasone increases Nr4a1 in Kupffer cells ameliorating acute liver failure in mice in a glucocorticoid receptor-dependent manner.
Deng JW; Yang Q; Cai XP; Zhou JM; E WG; An YD; Zheng QX; Hong M; Ren YL; Guan J; Wang G; Lai SJ; Chen Z
J Zhejiang Univ Sci B; 2020 Sept.; 21(9):727-739. PubMed ID: 32893529
[TBL] [Abstract][Full Text] [Related]
26. Timing of glucocorticoid administration determines severity of lipid metabolism and behavioral effects in rats.
Wu T; Jiang J; Yang L; Li H; Zhang W; Chen Y; Zhao B; Kong B; Lu P; Zhao Z; Zhu J; Fu Z
Chronobiol Int; 2017; 34(1):78-92. PubMed ID: 27791398
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
28. Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
Lu YS; Lien HC; Yeh PY; Yeh KH; Kuo ML; Kuo SH; Cheng AL
World J Gastroenterol; 2005 Oct; 11(40):6373-80. PubMed ID: 16419168
[TBL] [Abstract][Full Text] [Related]
29. Chronic glucocorticoid treatment induced circadian clock disorder leads to lipid metabolism and gut microbiota alterations in rats.
Wu T; Yang L; Jiang J; Ni Y; Zhu J; Zheng X; Wang Q; Lu X; Fu Z
Life Sci; 2018 Jan; 192():173-182. PubMed ID: 29196049
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
[TBL] [Abstract][Full Text] [Related]
31. Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone.
Haim YO; Unger ND; Souroujon MC; Mittelman M; Neumann D
Sci Rep; 2014 Mar; 4():4323. PubMed ID: 24608810
[TBL] [Abstract][Full Text] [Related]
32. Synergy between Interleukin-1
Bansal A; Kooi C; Kalyanaraman K; Gill S; Thorne A; Chandramohan P; Necker-Brown A; Mostafa MM; Milani A; Leigh R; Newton R
Mol Pharmacol; 2023 Dec; 105(1):23-38. PubMed ID: 37863662
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells.
Nehmé A; Lobenhofer EK; Stamer WD; Edelman JL
BMC Med Genomics; 2009 Sep; 2():58. PubMed ID: 19744340
[TBL] [Abstract][Full Text] [Related]
34. Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance.
Li J; Du J; Liu D; Cheng B; Fang F; Weng L; Wang C; Ling C
Arthritis Res Ther; 2014 May; 16(3):R106. PubMed ID: 24887434
[TBL] [Abstract][Full Text] [Related]
35. Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids.
Hu W; Jiang C; Kim M; Yang W; Zhu K; Guan D; Lv W; Xiao Y; Wilson JR; Rader DJ; Pui CH; Relling MV; Lazar MA
Cell Metab; 2021 Aug; 33(8):1592-1609.e7. PubMed ID: 34233159
[TBL] [Abstract][Full Text] [Related]
36. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.
Jia Y; Viswakarma N; Fu T; Yu S; Rao MS; Borensztajn J; Reddy JK
Gene Expr; 2009; 14(5):291-306. PubMed ID: 19630272
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids differentially regulate expression of duodenal and renal calbindin-D9k through glucocorticoid receptor-mediated pathway in mouse model.
Lee GS; Choi KC; Jeung EB
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E299-307. PubMed ID: 16219669
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone-Induced Liver Enlargement Is Related to PXR/YAP Activation and Lipid Accumulation but Not Hepatocyte Proliferation.
Jiao T; Yao X; Zhao Y; Zhou Y; Gao Y; Fan S; Chen P; Li X; Jiang Y; Yang X; Gonzalez FJ; Huang M; Bi H
Drug Metab Dispos; 2020 Sep; 48(9):830-839. PubMed ID: 32561593
[TBL] [Abstract][Full Text] [Related]
39. Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids.
Liu H; Liu D; Ji M; Xiao P; Qin Y; Zhao J; Wang N; Gou J; Yin T; He H; Chen G; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 622():121900. PubMed ID: 35690305
[TBL] [Abstract][Full Text] [Related]
40. Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects.
Jia Z; Wang X; Wei X; Zhao G; Foster KW; Qiu F; Gao Y; Yuan F; Yu F; Thiele GM; Bronich TK; O'Dell JR; Wang D
ACS Nano; 2018 Aug; 12(8):7663-7681. PubMed ID: 29965725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
